Tvardi Therapeutics, Inc.

TVRD · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
221
SEC Filings
$3.17
Close 2026-06-02
12
Employees

Business Summary

PartI Item1A. Risk Factors of this Annual Report on Form10-K for a discussion of material factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this Annual Report on Form10-K will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant u...

Latest Stock Quote

TVRD 2026-06-02 $3.17 O:$3.13 H:$3.2497 L:$3.11 Vol:0.0M VWAP:$3.1759
origin leaf: 62d1fc9fef21e58da613cf9446c170e2ea74fb7230d13a08f4840d2efd9c8759

Next Earnings

Q2 FY2026 — expected 2026-08-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001104659-26-037729EDGAR111K words
2025-03-112024-12-310001558370-25-002705EDGAR
2024-03-062023-12-310001558370-24-002609EDGAR
2023-03-062022-12-310001558370-23-002913EDGAR
2022-03-012021-12-310001558370-22-002555EDGAR
2021-02-252020-12-310001558370-21-001839EDGAR
2020-02-272019-12-310001558370-20-001659EDGAR
2019-03-122018-12-310001564590-19-007389EDGAR
2018-03-152017-12-310001564590-18-005879EDGAR
2017-03-102016-12-310001193125-17-077107EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001104659-25-111289EDGAR80K words
2025-08-142025-06-300001558370-25-011562EDGAR
2025-05-132025-03-310001558370-25-007575EDGAR
2024-11-142024-09-300001558370-24-015713EDGAR
2024-08-142024-06-300001558370-24-012231EDGAR
2024-05-132024-03-310001558370-24-007964EDGAR
2023-11-132023-09-300001558370-23-018837EDGAR
2023-08-072023-06-300001558370-23-013598EDGAR
2023-05-152023-03-310001558370-23-009845EDGAR
2022-11-072022-09-300001558370-22-016625EDGAR
2022-08-082022-06-300001558370-22-012626EDGAR
2022-05-092022-03-310001558370-22-007824EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001104659-26-037724EDGAR3K words
2026-03-060001104659-26-024676EDGAR
2026-01-160001104659-26-004273EDGAR
2025-12-180001104659-25-122615EDGAR
2025-11-190001104659-25-113901EDGAR
2025-11-130001104659-25-111310EDGAR
2025-10-140001104659-25-098908EDGAR
2025-08-140001104659-25-078665EDGAR
2025-07-140001104659-25-067785EDGAR
2025-06-090001104659-25-057524EDGAR

221 total filings indexed. 189 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001346830
TickerTVRD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.tvarditherapeutics.com
Listed2025-04-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 81f19bf556654e85fb94b621860d9b7d4767c273a531fd4b59d61d3b79cd0f3e
parent: 594270a3a884d9a49c2bc6f24e6f9f85bcf4cf7dfd1b69ce95b6cca4fdadc8a0
content hash: de7f5690d2fc10a6111f3119917d4b7b227706ca2a0e9c5dcbde5f8a88d720cd
signed: 2026-06-03T12:02:52.412Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf